Back
IGM Biosciences Vs. Xilio Therapeutics Industry Stock Comparison
Sell
48
IGMS
IGM Biosciences
Last Price:
9.18
Seasonality Move:
12.17%
Sell
23
XLO
Xilio Therapeutics
Last Price:
1.14
Seasonality Move:
-9.7%
Sell
48
IGM Biosciences (IGMS)
is a Sell
Is IGM Biosciences a Buy, Sell or Hold?
- The current IGM Biosciences [IGMS] share price is $9.29. The Score for IGMS is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- IGMS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Xilio Therapeutics (XLO)
is a Sell
Is Xilio Therapeutics a Buy, Sell or Hold?
- The current Xilio Therapeutics [XLO] share price is $1.08. The Score for XLO is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
- XLO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
IGMS Stock Price Chart
What is IGM Biosciences's stock price today?
-
The IGM Biosciences share price today is $9.29
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IGMS is experiencing slight selling pressure.
XLO Stock Price Chart
What is Xilio Therapeutics's stock price today?
-
The Xilio Therapeutics share price today is $1.08
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XLO is experiencing slight selling pressure.
IGMS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.07 | Buy |
| Relative Strength Index (14 RSI): | 49.8 | Sell |
| Chaikin Money Flow: | -56994 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.02 - 9.92) | Buy |
| Bollinger Bands (100): | (8.38 - 12.66) | Sell |
XLO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 47.23 | Sell |
| Chaikin Money Flow: | -44574 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.06 - 1.24) | Sell |
| Bollinger Bands (100): | (0.59 - 1.13) | Buy |
IGMS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.49 | Sell |
| 20-day SMA: | 9.05 | Buy |
| 50-day SMA: | 9.33 | Sell |
| 200-day SMA: | 8.49 | Buy |
| 8-day EMA: | 9.41 | Sell |
| 20-day EMA: | 9.29 | Sell |
| 50-day EMA: | 9.54 | Sell |
| 200-day EMA: | 10.07 | Sell |
XLO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.17 | Sell |
| 20-day SMA: | 1.12 | Sell |
| 50-day SMA: | 1.05 | Buy |
| 200-day SMA: | 1.41 | Sell |
| 8-day EMA: | 1.13 | Sell |
| 20-day EMA: | 1.14 | Sell |
| 50-day EMA: | 1.06 | Buy |
| 200-day EMA: | 1.45 | Sell |
IGM Biosciences Earnings Growth & IGMS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.40 per share, an increase next quarter of $0.07 per share, an increase this year of $2.13 per share, and a decrease next year of $0.06 per share.
Xilio Therapeutics Earnings Growth & XLO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.26 per share, an increase next quarter of $0.42 per share, an increase this year of $0.94 per share, and an increase next year of $0.50 per share.
IGM Biosciences Technical Analysis
| May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Xilio Therapeutics Technical Analysis
| May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||